Analysis of Lipid Biomarkers of Exposure and Host Response
Status:
Unknown status
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this prospective, open-label, clinical trial is to establish the feasibility
and validity of exhaled breath condensate (EBC) biomarkers for use in studies designed to
evaluate harm reduction strategies of smoking. This will be accomplished by measuring
selected markers in EBC believed related to the pathogenesis of lung disease before and after
a smoking cessation intervention.